​

Celcuity (CELC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CELC Stock Forecast

Celcuity (CELC) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $115.20, with a high of $141.00 and a low of $77.00. This represents a -8.02% decline from the last price of $125.25.

- $30 $60 $90 $120 $150 High: $141 Avg: $115.2 Low: $77 Last Closed Price: $125.25

CELC Stock Rating

Celcuity stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (88.89%), 1 Hold (11.11%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 9 0 1 8 Strong Sell Sell Hold Buy Strong Buy

CELC Price Target Upside V Benchmarks

TypeNameUpside
StockCelcuity-8.02%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts136
Avg Price Target$141.00$124.33$111.83
Last Closing Price$125.25$125.25$125.25
Upside/Downside12.57%-0.73%-10.71%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26191--11
Mar, 26191--11
Feb, 26191--11
Jan, 26191--11
Dec, 25181--10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 26, 2026Craig-Hallum$141.00$114.8122.81%12.57%
Mar 12, 2026Kalpit PatelWolfe Research$110.00$110.73-0.66%-12.18%
Mar 10, 2026Gil BlumNeedham$122.00$115.945.23%-2.59%
Dec 12, 2025Wells Fargo$126.00$100.7025.12%0.60%
Oct 22, 2025Swayampakula RamakanthH.C. Wainwright$77.00$65.2218.06%-38.52%
Oct 20, 2025Needham$95.00$72.1431.69%-24.15%
Aug 15, 2024Bradley CaninoStifel Nicolaus$39.00$16.57135.37%-68.86%
May 30, 2024Bradley CaninoStifel Nicolaus$40.00$15.28161.78%-68.06%
Mar 28, 2024Gil BlumNeedham$24.00$18.1632.16%-80.84%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 26, 2026Craig-HallumBuyBuyhold
Mar 12, 2026Wolfe ResearchOutperformOutperformhold
Mar 10, 2026NeedhamBuyBuyhold
Dec 12, 2025Wells FargoOverweightinitialise
Nov 25, 2025JefferiesBuyBuyhold
Oct 22, 2025H.C. WainwrightBuyBuyhold
Oct 20, 2025NeedhamBuyBuyhold
Sep 22, 2025GuggenheimBuyinitialise
Aug 18, 2025H.C. WainwrightBuyBuyhold
Aug 15, 2024Cowen & Co.BuyBuyhold

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.69$-2.83$-3.78---
Avg Forecast$-2.78$-2.63$-3.16$-3.16$-0.79$0.77
High Forecast$-2.54$-2.30$-2.40$-2.64$0.81$0.77
Low Forecast$-3.01$-2.79$-4.21$-4.35$-2.97$0.77
Surprise %-3.24%7.60%19.62%---

Revenue Forecast

$0 $70M $140M $210M $280M $350M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast-$5.04M$1.22M$50.47M$235.69M$340.61M
High Forecast-$5.04M$1.22M$50.47M$239.79M$340.61M
Low Forecast-$5.04M$1.22M$50.47M$231.59M$340.61M
Surprise %------

Net Income Forecast

$-200M $-150M $-100M $-50M $0 $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-63.78M$-111.78M$-177.04M---
Avg Forecast$-63.78M$-60.23M$-78.30M$-82.76M$-48.64M$18.31M
High Forecast$-60.07M$-54.41M$-56.80M$-62.51M$19.15M$18.31M
Low Forecast$-71.27M$-66.05M$-99.81M$-103.01M$-70.31M$18.31M
Surprise %-85.59%126.10%---

CELC Forecast FAQ

Is Celcuity stock a buy?

Celcuity stock has a consensus rating of Buy, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Celcuity is a favorable investment for most analysts.

What is Celcuity's price target?

Celcuity's price target, set by 9 Wall Street analysts, averages $115.2 over the next 12 months. The price target range spans from $77 at the low end to $141 at the high end, suggesting a potential -8.02% change from the previous closing price of $125.25.

How does Celcuity stock forecast compare to its benchmarks?

Celcuity's stock forecast shows a -8.02% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Celcuity over the past three months?

  • April 2026: 9.09% Strong Buy, 81.82% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 9.09% Strong Buy, 81.82% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 9.09% Strong Buy, 81.82% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.

What is Celcuity’s EPS forecast?

Celcuity's average annual EPS forecast for its fiscal year ending in December 2026 is $-3.16, marking a -16.40% decrease from the reported $-3.78 in 2025. Estimates for the following years are $-0.79 in 2027, and $0.77 in 2028.

What is Celcuity’s revenue forecast?

Celcuity's average annual revenue forecast for its fiscal year ending in December 2026 is $50.47M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $235.69M, and $340.61M for 2028.

What is Celcuity’s net income forecast?

Celcuity's net income forecast for the fiscal year ending in December 2026 stands at $-82.76M, representing a -53.25% decrease from the reported $-177M in 2025. Projections indicate $-48.639M in 2027, and $18.31M in 2028.